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Abstract: Gorgonian octocorals are considered a prolific source of secondary metabolites with a 
wide range of biological activities, including anti-inflammatory activity. In particular, the genus 
Briareum is known for producing a wealth of diterpenes with complex chemical structures. The 
chemical study of the methanolic extract of Briareum asbestinum collected in Bocas del Toro, on the 
Caribbean side of Panama, led to the isolation of three new eunicellin-type diterpenes: briarellin T 
(1), asbestinin 27 (2), asbestinin 28 (3) and the previously described asbestinin 17 (4). The structures 
of the new compounds were determined by extensive NMR analyses and HRMS. 
Anti-inflammatory activity assays showed a significant reduction of the pro-inflammatory 
cytokines TNF-α, IL-6, IL-1β and IL-8 as well as a downregulation of COX-2 expression in 
LPS-stimulated THP-1 macrophages. These findings support the potential use of these marine 
compounds as therapeutic agents in the treatment of inflammatory diseases. 
Keywords: asbestinins; briarellins; eunicellin diterpenes; Briareum; cytokines; cyclooxygenase-2  
 
1. Introduction 
Acute inflammation is a biological response to pathogens, toxic agents, tissue damage or 
radiation. This process is a defense mechanism aimed to remove harmful stimuli and restore tissue 
homeostasis. Nevertheless, uncontrolled acute inflammation can trigger a chronic inflammatory 
process, which is related to several diseases, such as cancer, rheumatoid arthritis, asthma, 
inflammatory bowel disease, multiple sclerosis, or cardiovascular diseases [1]. Currently, many 
researchers are focused on the search for new anti-inflammatory molecules, since there is interest in 
finding more effective therapies with fewer side effects than those currently used. 
Traditionally, terrestrial natural products have been extensively investigated due to their 
beneficial properties. However, the need of new therapeutic compounds has given rise to a vast 
number of studies in marine environments, a resource with huge potential for drug development 
[2,3]. Gorgonian octocorals are considered a rich source of secondary metabolites due to their 
capacity for producing a diversity of diterpenes with approximately 40 different carbon skeletons 
[4–7]. In particular, the genus Briareum produces diterpenes of the briarane class and the 
eunicellin-type, such as the briarellins and the asbestinins [4–8]. Briarellins and asbestinins along 
with the eunicellins (cladiellins) belong to a series of 2,11-cyclized cembranoids that share an 
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oxatricyclo [6.6.1.02,7] pentadecane core. Briareins, briarellins and asbestinins have shown a wide 
range of biological activities including cytotoxic, antiviral, anti-inflammatory, antimicrobial, 
antifouling and antiprotozoal activities [5,8,9], revealing the pharmacological potential of these 
compound families.  
Along the Caribbean coast of Panama, two species of Briareum have been reported, B. polyanthes 
and B. asbestinum. Of these, B. asbestinum has been chemically studied, with our group reporting 
eunicellin-based diterpenes with inhibitory activity on the production of nitric oxide (NO) induced 
by lipopolysaccharide (LPS) in macrophages [10]. The aim of this research was to reexamine a 
diterpene-rich fraction of B. asbestinum collected in Bocas del Toro, Panama. Our findings led to the 
isolation and identification of four additional eunicellin-based diterpenes including the new 
briarellin T (1), two new asbestinins 27 and 28 (2–3), and the known asbestinin 17 (4). In addition, we 
described for the first time the anti-inflammatory properties of these compounds as inhibitors of the 
pro-inflammatory cytokines tumor necrosis factor alpha (TNF-α), interleukin 6 (IL)-6, IL-1β, and 
IL-8 as well as cyclooxygenase 2 (COX-2) expression in LPS-induced THP-1 macrophages.  
2. Results and Discussion 
2.1. Isolation and Characterization of Diterpenes 
The octocoral Briareum asbestinum was collected by hand using SCUBA at 10 m in Isla San 
Cristobal, Bocas del Toro, Panama. The coral was minced and extracted with n-hexane, ethyl acetate 
and methanol. The methanol extract was pre-fractionated using reverse phase solid phase 






































































Figure 1. Structures of isolated compounds 1–4. 
Briarellin T (1) was isolated as a glassy solid, and its molecular formula was determined as 
C28H44O6Na based on HR-ESITOFMS data (m/z 499.3014, [M + Na]+). Seven degrees of unsaturation 
were calculated from the molecular formula: three accounted for carbonyls of ester and ketone and 
one double bond, hence compound 1 possesses four rings. Detailed analysis of 1H and 13C NMR data 
indicated the structure of briarellin T (1) was similar to briarellin S, previously reported from our 
group [10]. 13C-NMR and DEPT spectra showed the presence of one ketone (δC 214.3), one ester 
carbonyl (δC 173.5), one double bond (δC 124.8, 129.9) and five methyl groups (δC 11.4, 19.6, 18.8, 22.6, 
14.0) (Table 1). Additionally, resonances for six oxygenated carbon atoms corresponded to three 
methines (δC 95.3, 71.7, 79.5), one methylene (δC 66.9), and two quaternary (δC 80.3, 75.8). The 
remaining carbons corresponded to four sp3 methines (δC 37.8, 51.9, 38.0, 35.1), three sp3 methylenes 
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(δC 29.0, 44.6, 38.9), and six methylenes characteristic of a fatty acid chain (δC 34.6, 25.1, 28.9, 28.8, 
31.7, 22.6).  
Analysis of the 1H-NMR spectrum evidenced signals of five methyl groups: two, attached to sp3 
quaternary carbons bearing oxygen (δH 1.38, s; 1.43, s); one attached to a sp3 methine (δH 0.79, d, J = 
7.1 Hz); one attached to a sp2 carbon (δH 1.88, s); and one corresponded with the terminus of a fatty 
acid chain (δH 0.88, t, J = 7.0 Hz) (Table 1). A branched spin system composed of one methyl group 
(δH 0.79, d), three diastereotopic methylenes (δH 3.30/3.78; 2.05/2.62; 2.34/2.41) and six methines (δH 
1.88, 2.32, 2.53, 4.09, 2.31 and 4.69) was connected throughout COSY correlations (Figure 2). A 
separated spin system composed of one oxygenated methine (δH 5.33, m), one methylene (δH 
2.14/2.76), and one olefinic proton (δH 5.37, m) was also assigned through COSY experiments. The 
remaining protons were consistent with the methylenes of a fatty acid chain (δH 2.34, m; 1.62, m; 1.29, 

























COSY HMBC  
Figure 2. Correlation spectroscopy (COSY) and key heteronuclear multiple bond correlation (HMBC) 
of compounds 1–3. 
All functional groups and spin systems described above were connected through J2,3 HMBC 
correlations (Figure 2) as follows: methyl H-17 showed correlations to carbons C-14, C-15 and C-16;  
methyl H-18 showed correlations to carbons C-2, C-3 and C-4; methyl H-19 showed correlations 
with carbons C-6, C-7 and C-8; and methyl H-20 showed correlations with carbons C-10, C-11 and 
C-12. In this way the tetracyclic structure of the diterpenic nucleus was assembled. A J3 HMBC 
correlation observed between proton H-4 with carbonyl C-21 indicated the fatty acid moiety was 
attached to carbon C-4. 
The relative stereochemistry of compound 1 was assigned using 1D NOE experiments (Figure 
3). Irradiation of methyl H-20 produced a strong enhancement of protons H-2, H-9 and H-14, 
whereas irradiation on methyl H-18 produced an enhancement on proton H-2. All these protons 
(H-2, H-9, H-14 and H-20) were assigned arbitrarily with α-configuration. Irradiation of methyl H-17 
produced a strong enhancement of protons H-1, H-10 and H-19, while irradiation of H-1 enhanced 
H-4, H-10, H-17 and H-19; hence H-1, H-4, H-10 and H-17 were assigned with β-configuration. The 
geometry of the C-6/C-7 double bond was determined as E based on the 13C NMR chemical shifts of 
carbons C-8 and C-19 [11,12]. Moreover, the enhancement of H-19 when H-17 and H-1 were 
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Figure 3. Selected 1D NOE correlations of compounds 1–3. 
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Asbestinin 27 (2) was also isolated as a glassy solid. Its molecular formula was determined as 
C26H40O6K based on the interpretation of the HR-ESITOFMS data (m/z 487.2452, [M + K]+). Seven 
degrees of unsaturation were calculated from the molecular formula: three accounted for two 
carbonyls and one double bond, hence compound 2 was deduced to be tetracyclic. 
Table 1. NMR spectroscopic data of briarellin T (1) acquired in CDCl3 at 400 MHz. 
Position δC, mult. a δH, mult. (J in Hz) b HMBC COSY 
1 37.8, CH 2.53, dt (10.7, 8.5) 11 2, 10, 14 
2 95.3, CH 4.09. d (8.5) 4, 9, 14, 18 1 
3 80.3, C a    
4 71.7, CH a,b 5.33, m (overlap) 5, 21 5 
5a 29.0, CH2 2.76, ddd (14.6, 9.2, 6.3)  4, 6 
5b  2.14, m (overlap)   
6 124.8, CH 5.36, m (overlap) 8, 19 5 
7 129.9, C    
8a 44.6, CH2 2.62, dd (13.5, 6.8) 19 9 
8b  2.05, m (overlap)   
9 79.5, CH 4.64, dd (6.6, 2.4) 2, 7, 10 8, 10 
10 51.9, CH 2.32, dt (8.7, 8.0, 2.7)  1, 9 
11 75.8, C    
12 214.3, C    
13a 38.9, CH2 2.41, m 12, 14 14 
13b  2.34, m   
14 38.0, CH 2.32, m (overlap) 1, 12,  1, 13, 15 
15 35.1, CH 1.88, s  14, 16, 17 
16a 66.9, CH2 3.78, dd (13.7, 3.6) 3, 17 15 
16b  3.30, dd, (13,7, 6.2)   
17 11.4, CH3 0.79, d (7.1) 14, 15, 16 15 
18 20.5, CH3 1.38, s 2, 3, 4  
19 18.8, CH3 1.89, s 6, 7, 8  
20 22.6, CH3 1.43, s 10, 11, 12  
21 173.5, C    
22 34.6, CH2 2.34, m   
23 25.1, CH2 1.62, m 21  
24 28.9 *, CH2 1.29, m   
25 28.9 *, CH2 1.29, m   
26 31.7, CH2 1.25, m   
27 22.6, CH2 1.27, m  28 
28 14.0, CH3 0.88, t (7.0) 26, 27 27 
a δC values were obtained by the assistance of the HMBC correlations; b δC values were obtained by 
the assistance of the heteronuclear single-quantum correlation spectroscopy (HSQC); * This values 
can be exchanged. 
Detailed analysis of the 1D and 2D NMR data (Table 2, Figure 2) revealed that compound 2 is a 
diterpene analog to asbestinin 1 [13]. Main differences consisted in the positions of the acetate and 
butyrate moieties attached to C-11 and C-4 of compound 2, respectively (confirmed by HMBC data, 
Figure 2); instead of the acetate and butyrate moieties attached to C-4 and C-11 in asbestinin 1. 
Relative configuration of compound 2 was determined on the basis of NOE experiments as depicted 
in Figure 3. 
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Table 2. NMR spectroscopic data of asbestinins 27 (2) and 28 (3) acquired in CDCl3 at 400 MHz. 
 Asbestinin 27 (2)  Asbestinin 28 (3) 
Position δC, mult. a δH, mult. (J in Hz) b  δC, mult. δH, mult. (J in Hz) 
1 38.3, CH 2.27, m  38.3, CH 2.27, dt (10.8, 8.3)  
2 94.6, CH 4.04. d (8.5) 94.6, CH 4.01. m 
3 79.1, C  79.1, C  
4 72.4, CH 5.33, m  72.7, CH 5.31, m  
5a 29.1, CH2 2.71, dt (14.9, 8.1) 29.1, CH2 2.71, ddd (14.7, 9.3, 6.2) 
5b  2.08, m   2.08, m  
6 125.1, CH 5.32, m  124.9, CH 5.31, m  
7 129.4, C  129.4, C  
8a 44.3, CH2 2.47, dd (13.4, 6.5) 44.3, CH2 2.47, dd (13.3, 6.5) 
8b  2.02, m   2.02, m  
9 80.9, CH 4.06, dd (8.9, 2.5) 80.9, CH 4.04, m 
10 48.4, CH 2.09, m 48.3, CH 2.08, m 
11 73.8, CH 5.30, m 73.8, CH 5.31, m 
12 31.0, CH 1.97, m 31.0, CH 1.97, m 
13a 31.3, CH2 1.47, dt (13.6, 9.8) 31.3, CH2 1.47, dt (13.6, 9.8) 
13b  0.98, m  1.00, dt (13.6, 2.7) 
14 37.7, CH 1.87, m  37.7, CH 1.90, m  
15 36.7, CH 1.69, m 36.7, CH 1.73, m 
16a 67.6, CH2 3.84, dd (13.3, 2.4) 67.7, CH2 3.85, dd (13.5, 2.4) 
16b  3.36, dd, (13.3, 5.1)  3.37, dd, (13.5, 5.0) 
17 11.4, CH3 0.76, d (7.1) 11.3, CH3 0.76, d (7.1) 
18 19.7, CH3 1.35, s 19.7, CH3 1.34, s 
19 18.8, CH3 1.87, s 18.8, CH3 1.86, s 
20 18.1, CH3 0.91, d (7.2) 18.1, CH3 0.91, d (7.1) 
21 171.4, C  171.4, C  
22 21.3, CH3 2.11, s 21.4, CH3 2.11, s 
23 173.3, C  170.7, C  
24 36.6, CH2 2.30, t (7.3) 21.3, CH3 2.07, s 
25 18.6, CH2 1.66, m   
26 13.6 CH3 0.96, t (7.4)   
a δC values were obtained by the assistance of the HMBC correlations; b δC values were obtained by 
the assistance of the HSQC correlations. 
Asbestinin 28 (3) was also isolated as a glassy solid. Its molecular formula was determined as 
C24H36O6K based on the interpretation of the HR-ESITOFMS data (m/z 459.2139, [M + K]+). Seven 
degrees of unsaturation were calculated from the molecular formula of asbestinin 28 (3): three 
unsaturations accounted for two carbonyls and one double bond, hence compound 3 was deduced 
to be tetracyclic as compounds 1 and 2. 1D and 2D NMR data of compounds 2 and 3 were almost 
identical (Table 2, Figures 2 and 3). The asbestinin core was the same in both compounds 2 and 3. 
The main difference was the presence of an acetate group attached to C-4 in asbestinin 28 (3) instead 
of the butyrate moiety attached to the same carbon in asbestinin 27 (2). The lack of two methylenes 
(−28 Daltons) was evident in the molecular formula of compound 3 compared with compound 2. 
Relative stereochemistry of compound 3 was determined on the basis on NOE experiments, as 
depicted in Figure 3. 
2.2. Anti-Inflammatory Activity 
Briarellins and asbestinins are biologically active marine natural products with great 
pharmacological potential due to their variety of properties, including antimicrobial, antiviral, 
antimalarial, and cytotoxic activities [9,14]. Moreover, a previous study from our group has reported 
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that briarellin S reduced NO levels in LPS-stimulated primary murine macrophages [10]. However, 
there is no more evidence that reports the anti-inflammatory activity of these marine compounds. In 
the present study, the diterpenes obtained from the octocoral Briareum asbestinum were tested for 
their in vitro anti-inflammatory activity, by measuring the production of pro-inflammatory 
cytokines.  
Assays were conducted on human THP-1 monocytes transformed into macrophages, which are 
a useful in vitro model to test anti-inflammatory molecules, since their stimulation by LPS induces 
pro-inflammatory mediator’s production [15]. In order to select non-cytotoxic concentrations of the 
compounds, THP-1 cell viability was carried out by using the SRB assay and a maximum 
concentration of 50 μM was assayed (Table S1). THP-1 macrophages were pretreated with the 
compounds at 10, 20 and 50 µM for 1 h, and then stimulated with LPS (1 µg/mL) for 24 h. As shown 
in Figure 4, LPS induced a significant increase in the production of TNF-α, IL-6 and IL-1β in THP-1 
cells in relation to unstimulated control cells (p < 0.001). These molecules are potent 
pro-inflammatory cytokines produced by immune cells at the site of inflammation, and play a 
crucial role in local and systemic inflammatory responses [16]. Dexamethasone, used as an 
anti-inflammatory reference drug, strongly inhibited LPS-induced TNF-α, IL-6, and IL-1β 
production. Similarly, pretreatment of cells with all the diterpenes substantially reduced cytokine 
levels; these anti-inflammatory effects were more marked at the concentration of 50 μM (p < 0.001) 
(Figures 4A, 4B and 4C). The cytokine IL-8 is a potent chemoattractant agent for neutrophils as well 
as regulates angiogenesis and metastasis [14]. Treatment with the compounds briarellin T (1), 
asbestinin 27 (2) and asbestinin 28 (3) resulted in a significant suppression of cytokine levels at the 
highest concentration (p < 0.05, p < 0.001 and p < 0.05, respectively), comparable to dexamethasone (p 
< 0.01) (Figure 4D). 
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Figure 4. Effect of the diterpenes briarellin T, and asbestinin 17, 27 and 28 on lipopolysaccharide 
(LPS)-induced TNF-α (A), IL-6 (B), IL-1β (C) and IL-8 (D) production by THP-1 macrophages. Cells 
(105 cells/mL) were pre-treated with diterpenes (10, 20 and 50 μM) or dexamethasone (Dex, 1 μM) for 
1 h. Afterwards, the macrophages were stimulated with LPS (1 µg/mL) for 24 h. Data are the means ± 
SEM of four independent experiments. Mean value was significantly different compared with the 
unstimulated group (*** p <0.001; Student t test). Mean value was significantly different compared 
with LPS-stimulated cells (+ p <0.05, ++ p <0.01, +++ p <0.001; one-way ANOVA followed by 
Bonferroni’s Multiple Comparison test). 
The inducible enzyme COX-2 has also been reported to have a key role in the inflammatory 
response by overproducing pro-inflammatory prostaglandins such as PGE2 [17]. In order to 
elucidate the possible mechanism by which these kind of diterpenes exerts their anti-inflammatory 
effects, we examined COX-2 expression by Western Blotting. THP-1 macrophages were pretreated 
with the compounds (10, 20 and 50 μM) for 1h, and then stimulated with LPS (1 µg/mL). As 
presented in Figure 5, exposure of THP-1 cells to LPS induced a pronounced increase in COX-2 
protein levels compared with unstimulated THP-1 macrophages (p < 0.01). As expected, the 
reference compound dexamethasone markedly inhibited the expression of this enzyme (p < 0.05). 
LPS-induced COX-2 expression was significantly attenuated after pretreatment with the compounds 
asbestinin 17 (4) and asbestinin 27 (2) at 50 μM (p < 0.05). The compound asbestinin 28 (3) exhibited 
the highest inhibitory activity, reducing COX-2 levels with all concentrations used. Interestingly, this 
compound drastically decreased protein expression to basal levels at 20 and 50 μM (p < 0.01). 
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Figure 5. Effect of the diterpenes briarellin T, and asbestinin 17, 27, and 28 on lipopolysaccharide 
(LPS)-induced cyclooxygenase-2 (COX-2) expression by THP-1 macrophages. Cells (106 cells/mL) 
were pre-treated with the diterpenes (10, 20 and 50 μM) or dexamethasone (Dex, 1 μM) for 1 h. 
Afterwards, the macrophages were stimulated with LPS (1 µg/mL) for 24 h. (A) Representative 
Western Blot analysis of COX-2 protein. (B) Densitometric data were studied after normalization to 
the housekeeping gene, β-actin. Data are the means ± SEM from four independent experiments. 
Mean value was significantly different compared with the unstimulated group (** p <0.01; Student t 
test). Mean value was significantly different compared with LPS-stimulated cells (+ p <0.05, ++ p 
<0.01; one-way ANOVA followed by Bonferroni’s Multiple Comparison test). 
3. Materials and Methods  
3.1. General Experimental Procedures  
Optical rotations were measured on a JASCO P-2000 polarimeter (JASCO, Easton, MD, USA). 
IR data was collected using a Bruker Alpha Fourier transform infrared spectrophotometer (Bruker, 
Billerica, MA, USA). NMR spectra were measured at 1H resonance frequency on a Jeol Eclipse + 400 
MHz spectrometer (JEOL, Peabody, MA, USA). Chemical shifts were calibrated internally to the 
residual signal of deuterated chloroform (CDCl3 δH 7.26, δC 77.0). For NMR measurements 
concentration used was in the range of 3–8 mg of compound (depending on the amount of 
compound available) dissolved in 600 μL of deuterated chloroform. High-resolution mass spectra 
were obtained on a Bruker micrOTOF-Q III (Bruker Daltonics, Billerica, MA, USA). HPLC 
separations were performed using an Agilent 1200 HPLC system equipped with a quaternary 
pump, a diode array detector (Agilent, Santa Clara, CA, USA) and a normal phase silica gel column 
(Phenomenex Sphereclone®, 4.6 mm × 100 mm, 5 μm). Reverse phase solid phase extraction (SPE) 
separation was carried out using SUPELCO SupelcleanTM LC-18 (C-18, octadecyl) solid-phase 
extraction cartridges (Supelco® Analytical, Bellefonte, PA, USA). 
3.2. Biological Material  
The octocoral Briareum asbestinum (Order Alcyonacea, Family Briaridae) was collected by hand 
using SCUBA at 10 m in Isla San Cristobal, located in the Caribbean Sea off the coast of Bocas del 
Toro, Panama in October 2014. The coral specimen was identified as Briareum asbestinum (Pallas) 
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based on its morphology and SEM-micrographs of the coral sclerites at the Smithsonian Tropical 
Research Institute (Ancon, Panama). A reference specimen is deposited at INDICASAT Center for 
Biodiversity and Drug Discovery under the number GLBO-061014-02.  
3.3. Extraction and Isolation  
The fresh organism (1242 g) was minced and exhaustively extracted with n-hexane, ethyl 
acetate and methanol. The organic extracts were evaporated separately in vacuo to give 4.1 g, 24.7 g 
and 28.6 g of the n-hexane, ethyl acetate and methanol extracts, respectively.  
The methanolic extract was fractionated using a reverse phase solid phase extraction (SPE) 
cartridge (1.0 g) eluted sequentially with 20, 40, 60, 80, and 100 % of methanol in water, obtaining 
five fractions (F1-F-5). 13C-NMR spectra of fraction F4 (80% MeOH in water, 1.7 g) revealed the 
presence of diterpenes with asbestinin and briarellin skeletons. Hence fraction F4 (53.0 mg) was 
purified by normal phase HPLC using a Phenomenex Sphereclone® column (250 × 10 mm) eluted 
with a gradient of 40%–100% of EtOAc in n-hexane, in 70 min at 1 mL/min, to yield 17 sub-fractions 
denoted as FI-FXVII. Fraction FV contained asbestinin 27 (2, 3.2 mg), fraction FIX contained 
asbestinin 28 (3, 12.7 mg), fraction FXI contained briarellin T (1, 8.7 mg) and fraction FXV contained 
asbestinin 17 (4, 5.1 mg).  
Briarellin T (1): Glassy solid; [α]D20 +70 (c 0.1, MeOH); IR (film) νmax 3422, 2962, 2853, 1724, 1659, 
1349, 1165, 1107, 999 cm−1; 1H and 13C NMR see Table 1; HRESI-TOF-MS m/z [M + Na]+ 499.3014 
(calcd for C28H44O6Na, 499.3030). 
Asbestinin 27 (2): Glassy solid; [α]D20 −103.3 (c 0.03, MeOH); IR (film) νmax 1664, 1403, 1106, 1013 
cm−1; 1H and 13C NMR see Table 2; HRESI-TOF-MS m/z [M + K]+ 487.2452 (calcd for C26H40O6K, 
487.2456). 
Asbestinin 28 (3): Glassy solid; [α]D20 +77.9 (c 0.2, MeOH); IR (film) νmax 1726, 1378, 1107, 998 cm−1; 
1H and 13C NMR see Table 2; HRESI-TOF-MS m/z [M + K]+ 459.2139 (calcd for C24H36O6K, 459.2143).   
3.4. Cell Culture 
Human acute monocytic leukemia cell line THP-1 was kindly provided by Professor Francisco 
Muriana of the Fat Institute (Consejo Superior de Investigaciones Científicas, Seville, Spain). Cells 
were maintained in RPMI 1640 media (GIBCO®, Life Technologies, New York, NY, USA) containing 
10% heat-inactivated fetal bovine serum, 100 U/mL penicillin and 100 μg/mL streptomycin (PAA, 
Pasching, Austria), in a humidified atmosphere containing 5% CO2 at 37 °C.  
3.5. Cell Proliferation Assay 
Cellular viability upon exposure to terpenes was evaluated by using the sulforhodamine B 
(SRB) method (Sigma-Aldrich Química, S.A., Spain) [18]. Briefly, the cells were seeded into 96-well 
plates at a density 105cells/mL (100 µL/well) and differentiated into macrophages with phorbol 
myristate acetate (PMA, Sigma-Aldrich Química, S.A., Madrid, Spain) at 0.2 μM for 72 h in a 
humidified atmosphere of 5% CO2 at 37 °C. The medium was then removed and cells were washed 
with cold phosphate saline buffer (PBS). Afterwards, macrophages were incubated for 24 h with 
different concentration of diterpenes (6.25, 12.5, 25, 50, and 100 μM). Compounds were prepared by 
dilution of stock solutions (10 mM) in dimethylsulfoxide (DMSO, Barcelona, Spain) and culture 
medium. Controls were incubated in medium with 0.1% v/v DMSO, not affecting cell viability. Next, 
the cells were fixed using 50 µL of 50% trichloroacetic acid (4 °C, 1 h) and washed several times 
with distilled water. After that, macrophages were stained with 0.4% SRB solution (50 µL) prepared 
in 1% acetic acid for 30 min at room temperature. After this time, the SRB solution was removed 
and the plates were washed with 1% acetic acid and air-dried. Finally, 10 mM Tris-base (100 µL) 
was added into each well to solubilize the cell-bound dye. The absorbance at 540 nm was measured 
in a microplate spectrophotometer (Sinergy HT, Biotek®, Bad Friedrichshall, Germany).   
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3.6. Determination of Cytokines Production 
THP-1 monocytes (105 cells/mL, 100 µL/well) were transformed into macrophages in presence 
of PMA (0.2 μM) in 96-well plates in a humidified atmosphere of 5% CO2 at 37 °C for 72 h. 
Afterwards, the medium was removed and the cells were washed twice with cold PBS. Next, cells 
were pre-treated with diterpenes (10, 20, and 50 μM) or the reference drug dexamethasone (1 μM), 
for 1 h. Subsequently, macrophages were stimulated with LPS from Escherichia coli (1 μg/mL) for 24 
h. Control groups (unstimulated and stimulated with LPS) were incubated with culture medium 
with DMSO (0.1% v/v). After incubation period, the supernatants were collected and kept at −80 °C 
until cytokines (TNF-α, IL-6, IL-1β and IL-8) measurements could be collected by commercial 
enzyme-linked immunosorbent assay (ELISA) kits (Diaclone GEN-PROBE, France), according to the 
manufacturer’s protocol. The absorbance was determined at 450 nm with a microplate reader 
(Labsystems Multiskan EX, Thermo Scientific, New York, NY, USA). To calculate the cytokines 
concentration, a standard curve was created using serial dilutions of cytokine standards provided 
with the kit. 
3.7. Isolation of Cytoplasmic Proteins and Analysis of Proteins Expression by Western Blot Assay 
THP-1 monocytes (106 cells/mL, 2 mL/well) were transformed into macrophages in presence of 
0.2 μM PMA in 6-well plates, for 72 h, in a humidified atmosphere of 5% CO2 at 37 °C. Then, the 
medium was removed and the cells were washed with cold PBS.  Subsequently, macrophages 
were pre-treated with diterpenes at concentrations of 10, 20, and 50 μM for 1 h and then stimulated 
with LPS (1 µg/mL) for 24 h. Dexamethasone (1 μM) was used as the positive reference compound. 
Control groups (unstimulated and stimulated with LPS) were incubated in culture medium with 
DMSO 0.1% (v/v). Then, cell pellets were mixed with cold lysis buffer (50 mM Tris-HCl pH 7.5, 8 
mM MgCl2, 5 mM ethylene glycol bis (2-aminoethyl ether)-N,N,N’N’-tetraacetic acid, 0.5 mM EDTA, 
1 mM phenylmethylsulfonyl fluoride, 250 mM NaCl, 0.01 mg/mL leupeptin, 0.01 mg/mL pepstatin 
and 0.01 mg/mL aprotinin). Next, cells were scraped and incubated on ice for 30 min. Finally, cell 
lysates were sonicated, spined (12,000 g, 4 °C) for 10 min and stored at −80 °C. Protein concentration 
of the homogenates was evaluated using the Bradford assay [19]. Aliquots of the supernatants 
containing 50 μg of protein were separated on acrylamide gel (10%) by sodium dodecyl sulphate 
polyacrylamide gel electrophoresis. Then, the proteins were transferred onto a nitrocellulose 
membrane and incubated with the primary antibody against COX-2 (1:5000, Cayman Chemical, 
Michigan, USA) at 4 °C overnight. Next, the blots were washed three times for 15 min and 
incubated with the HRP‐labeled secondary antibody ((1:5000, Pierce Chemical Company, Rockford, 
IL, USA) at room temperature for two hours. To prove equal loading, the membranes were 
incubated with an anti β-actin antibody (1:1000, Sigma Aldrich, St. Louis, MO, USA). 
Immunodetection was observed using an enhanced chemiluminescence light-detecting kit 
(Super-Signal West Pico Chemiluminescent Substrate; Thermo Scientific, New York, NY, USA). 
Densitometric data were evaluated after normalization to the housekeeping gene β-actin. The bands 
were analysed and quantified with a Scientific Imaging Systems (Biophotonics ImageJ Analysis 
Software; National Institute of Mental Health, Bethesda, MD, USA). 
3.8. Statistical Analysis 
All values in the figures and text are expressed as arithmetic means ± standard error of the 
mean (S.E.M.). Experiments were carried out in quadruple. Data were evaluated with GraphPad 
Prism software (Version No. 8, GraphPad Software, Inc., San Diego, CA, USA). Statistical 
significance between the two control groups (Control vs. LPS) was determined by Student’s t test. 
Statistical significance of any difference in each parameter between several groups was evaluated 
by one-way analysis of variance (ANOVA) followed by Bonferroni test. p values of <0.05 were 
considered statistically significant.  
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4. Conclusions 
Four eunicellin-based diterpenes: a briarellin (1) and three asbestinins (2–4) were isolated from 
the octocoral Briareum asbestinum and their structures determined by spectroscopic means. 
Compounds 1–3 are described for the first time. Moreover, we have demonstrated for the first time 
the anti-inflammatory activity of briarellin and asbestinin-type diterpenes through downregulation 
of the pro-inflammatory cytokines TNF-α, IL-6, IL-1β and IL-8 as well as reduction of COX-2 
expression in LPS-induced THP-1 macrophages. These studies support the potential use of these 
compounds as therapeutic agents in the treatment of inflammatory pathologies. Further 
investigations are needed to elucidate the mechanism of action of this interesting class of 
diterpenes.  
Supplementary Materials: The following are available online at www.mdpi.com, Figures S1–S24: 1D, 2D NMR 
and HRMS data of isolated compounds.  
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